Synopsis
Synopsis
0
VMF
0
FDF
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 525.1 g/mol |
---|---|
Molecular Formula | C23H33ClN6O4S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 8 |
Exact Mass | 524.1972524 g/mol |
Monoisotopic Mass | 524.1972524 g/mol |
Topological Polar Surface Area | 118 A^2 |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 854 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Vardenafil hydrochloride |
Drug Label | LEVITRA is an oral therapy for the treatment of erectile dysfunction. This monohydrochloride salt of vardenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).Vardenafil HCl is designated... |
Active Ingredient | Vardenafil hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg; 20mg |
Market Status | Prescription |
Company | Teva Pharms |
2 of 2 | |
---|---|
Drug Name | Vardenafil hydrochloride |
Drug Label | LEVITRA is an oral therapy for the treatment of erectile dysfunction. This monohydrochloride salt of vardenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).Vardenafil HCl is designated... |
Active Ingredient | Vardenafil hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg; 20mg |
Market Status | Prescription |
Company | Teva Pharms |
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-15
Pay. Date : 2015-08-21
DMF Number : 25174
Submission : 2011-08-02
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-02-20
Pay. Date : 2014-12-24
DMF Number : 28900
Submission : 2014-12-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33220
Submission : 2019-03-07
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-13
Pay. Date : 2013-07-10
DMF Number : 25795
Submission : 2012-04-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-01-05
Pay. Date : 2016-10-03
DMF Number : 30804
Submission : 2016-10-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32908
Submission : 2018-09-20
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Vardenafil Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vardenafil Hydrochloride, including repackagers and relabelers. The FDA regulates Vardenafil Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vardenafil Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vardenafil Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vardenafil Hydrochloride supplier is an individual or a company that provides Vardenafil Hydrochloride active pharmaceutical ingredient (API) or Vardenafil Hydrochloride finished formulations upon request. The Vardenafil Hydrochloride suppliers may include Vardenafil Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Vardenafil Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vardenafil Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Vardenafil Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Vardenafil Hydrochloride DMFs exist exist since differing nations have different regulations, such as Vardenafil Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vardenafil Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Vardenafil Hydrochloride USDMF includes data on Vardenafil Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vardenafil Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vardenafil Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vardenafil Hydrochloride Drug Master File in Japan (Vardenafil Hydrochloride JDMF) empowers Vardenafil Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vardenafil Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Vardenafil Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vardenafil Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Vardenafil Hydrochloride Drug Master File in Korea (Vardenafil Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Vardenafil Hydrochloride. The MFDS reviews the Vardenafil Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Vardenafil Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Vardenafil Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Vardenafil Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Vardenafil Hydrochloride suppliers with KDMF on PharmaCompass.
A Vardenafil Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Vardenafil Hydrochloride Certificate of Suitability (COS). The purpose of a Vardenafil Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vardenafil Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vardenafil Hydrochloride to their clients by showing that a Vardenafil Hydrochloride CEP has been issued for it. The manufacturer submits a Vardenafil Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vardenafil Hydrochloride CEP holder for the record. Additionally, the data presented in the Vardenafil Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vardenafil Hydrochloride DMF.
A Vardenafil Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vardenafil Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vardenafil Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Vardenafil Hydrochloride written confirmation (Vardenafil Hydrochloride WC) is an official document issued by a regulatory agency to a Vardenafil Hydrochloride manufacturer, verifying that the manufacturing facility of a Vardenafil Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vardenafil Hydrochloride APIs or Vardenafil Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Vardenafil Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Vardenafil Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vardenafil Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vardenafil Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vardenafil Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vardenafil Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vardenafil Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vardenafil Hydrochloride suppliers with NDC on PharmaCompass.
Vardenafil Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vardenafil Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vardenafil Hydrochloride GMP manufacturer or Vardenafil Hydrochloride GMP API supplier for your needs.
A Vardenafil Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Vardenafil Hydrochloride's compliance with Vardenafil Hydrochloride specifications and serves as a tool for batch-level quality control.
Vardenafil Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Vardenafil Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vardenafil Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Vardenafil Hydrochloride EP), Vardenafil Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vardenafil Hydrochloride USP).
LOOKING FOR A SUPPLIER?